Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes
Verified date | August 2019 |
Source | Universidade do Porto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.
Status | Completed |
Enrollment | 40 |
Est. completion date | June 30, 2019 |
Est. primary completion date | January 31, 2019 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 50 Years to 70 Years |
Eligibility |
Inclusion Criteria: - diagnosis of type 2 diabetes for at least 12 months; - glycated hemoglobin bellow 10 %; - not having started insulin therapy in the previous six months; - not having started therapy with sulfonylureas in the previous six months; - major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot); - no symptoms of coronary artery disease; - no cardiovascular, respiratory and musculoskeletal contraindications to exercise; - not under cancer treatment (radiotherapy or intravenous chemotherapy); - without limitations in gait or balance; - independent living in the community; - not engaged in supervised exercise; - non-smokers at least for 6 months. Exclusion Criteria: - cardiological stress test with cardiac or hemodynamic problems |
Country | Name | City | State |
---|---|---|---|
Portugal | Instituto de Saúde Pública da Universidade do Porto | Porto |
Lead Sponsor | Collaborator |
---|---|
Universidade do Porto | Administração Regional de Saúde do Norte, Portugal, Federação Portuguesa de Futebol, Portugal, Fédération Internationale de Football Association |
Portugal,
Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.
Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. B
Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Program
Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: Univer
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Exercise intensity - subjective internal load | OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points) | Through 3 months | |
Primary | Exercise intensity - objective internal load | Heart rate during exercise | Through 3 months | |
Primary | Exercise intensity - external load | Distance (km) assessed using GPS tracking during exercise | Through 3 months | |
Primary | Acute glycemic effect | Acute change in capillary blood glucose with exercise sessions | Change between before and immediately after each exercise session | |
Primary | Acute systolic blood pressure effect | Acute change in systolic blood pressure with exercise sessions | Change between before and immediately after each exercise session | |
Primary | Acute diastolic blood pressure effect | Acute change in diastolic blood pressure with exercise sessions | Change between before and immediately after each exercise session | |
Primary | Incidence of falls | Number of falls during the exercise program | Through 3 months | |
Primary | Incidence of foot injuries | Number of reported foot injuries during the exercise program | Through 3 months | |
Primary | Incidence of musculoskeletal injuries | Number of reported musculoskeletal injuries during the exercise program | Through 3 months | |
Primary | Rate of Enjoyment | Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points) | Through 3 months | |
Secondary | Glycemic control | Glycated hemoglobin (venous blood analysis) | Change from baseline to 3 months | |
Secondary | Blood lipid profile | Total cholesterol (venous blood analysis) | Change from baseline to 3 months | |
Secondary | Clinical systolic blood pressure | Resting systolic blood pressure | Change from baseline to 3 months | |
Secondary | Clinical diastolic blood pressure | Resting diastolic blood pressure | Change from baseline to 3 months | |
Secondary | Body mass index | Body mass index | Change from baseline to 3 months | |
Secondary | Waist circumference | Waist circumference | Change from baseline to 3 months | |
Secondary | Body fat | Body fat (bioelectrical impedance analysis) | Change from baseline to 3 months | |
Secondary | Body lean mass | Body lean mass (bioelectrical impedance analysis) | Change from baseline to 3 months | |
Secondary | Agility/balance | Timed Up and Go Test | Change from baseline to 3 months | |
Secondary | Habitual physical activity | Global Physical Activity Questionnaire | Change from baseline to 3 months | |
Secondary | Food pattern | 24h-food recall analysis | Change from baseline to 3 months | |
Secondary | Cognitive state | Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points) | Change from baseline to 3 months | |
Secondary | Health-related quality of life | EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points) | Change from baseline to 3 months | |
Secondary | Medication | Number of medications | Change from baseline to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |